Providers/Grant Support
Jointly provided by The Postgraduate Institute for Medicine (PIM) and DKBmed, LLC.
This activity is supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Credits Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses — 1.0 Nursing Contact Hours
- Physician Assistants — 1.0 AAPA Category 1 CME credits
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
The intended audience for this Clinician Webcast will be Physicians, Nurses and Nurse Practitioners and Physician Assistants.
Program Overview
Despite similar rates of depression across racial and ethnic groups, individuals from marginalized communities are significantly less likely to be diagnosed, treated, and supported effectively for major depressive disorder (MDD). It's time to change that.
Join us for an evidence-based webinar that will give you practical strategies to:
- Identify and address disparities in MDD diagnosis and treatment
- Improve adherence and outcomes through culturally responsive care
- Explore emerging therapies and treatment strategies for MDD and treatment-resistant depression
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss variation in depression diagnosis and treatment among individuals from racial and ethnic minority groups.
- Develop strategies that ensure treatment uptake and support treatment adherence in Black patients with MDD.
- Apply approved and emerging investigational therapeutic agents for MDD, once available, to treatment plans of Black patients with MDD.
Faculty
Lisa Harding, MD
Assistant Clinical Professor
Yale School of Medicine
Nathaniel Baffoe-Mensah, MD, MPH
Attending Physician
Penn Medicine LG Health Physician
Hospitalists
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine (PIM) and DKBmed LLC. PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Education
PIM designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hours.
PA Continuing Medical Education
PIM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until June 30, 2026. PAs should only claim credit commensurate with the extent of their participation.
Disclosures of Conflict of Interest
Lisa Harding, MD
- Employee/Owner: Mood Institute
- Research Support: PCORI
- Speaker: Janssen, GH Research, HMP Education, Clinical Care Alliance
- Consultant: Otsuka, Janssen, GH Research, Eli Lily, Compass Pathways
Nathaniel Baffoe-Mensah, MD, MPH
- None
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
To access activities, users will need:
- A computer with an internet connection
- An HTML5 compliant web browser or Internet Explorer 8 (and higher)
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participating and receiving CME/CE credit for this activity.
Contact Information
For additional information about the accreditation of this activity, please email [email protected]